Well, a day early. What I took away from it. Blah Blah Balh.....information already reported to market.....blah blah blah.......extra sites will take longer than previously reported.....blah blah blah...licensing agreement, these are expected to conclude early 2025! Whoa...the company is comfortable that they will engage a partner. OK then. If they don't..... - Ashland - I'm assuming they haven't received payment for December and January production. That could be another $500 000 - R and D loan - With the spend in sept and dec quarters that is another million. cash - 2.3 million all added up that could be approximately 3.3. million. December they say they have 1.55 quarters. That's enough to get halfway through may. Another mill gets them to july. They are cutting this razor thin unless they get a license agreement. BUT if they do sign an agreement then we could see a significant short term jump in the SP. I personally am so sick of reading about potential partners for CBD capsule. Three years? It's felt like a life time. I guess the sands through the hour glass are quickly coming to the end.
AVE Price at posting:
0.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)